Format

Send to

Choose Destination
Cell. 2014 Oct 23;159(3):477-86. doi: 10.1016/j.cell.2014.10.006. Epub 2014 Oct 16.

Camouflage and misdirection: the full-on assault of ebola virus disease.

Author information

1
Boston Children's Hospital, Department of Medicine, Division of Infectious Diseases, Boston, MA 02115, USA.
2
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: njsull@mail.nih.gov.

Abstract

Ebolaviruses cause a severe hemorrhagic fever syndrome that is rapidly fatal to humans and nonhuman primates. Ebola protein interactions with host cellular proteins disrupt type I and type II interferon responses, RNAi antiviral responses, antigen presentation, T-cell-dependent B cell responses, humoral antibodies, and cell-mediated immunity. This multifaceted approach to evasion and suppression of innate and adaptive immune responses in their target hosts leads to the severe immune dysregulation and "cytokine storm" that is characteristic of fatal ebolavirus infection. Here, we highlight some of the processes by which Ebola interacts with its mammalian hosts to evade antiviral defenses.

PMID:
25417101
PMCID:
PMC4243531
DOI:
10.1016/j.cell.2014.10.006
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center